Related references
Note: Only part of the references are listed.Open-label Phase 3 Continuation Study of Cholic Acid in Patients With Inborn Errors of Bile Acid Synthesis
James E. Heubi et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2020)
The cholic acid extension study in Zellweger spectrum disorders: Results and implications for therapy
Femke C. C. Klouwer et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2019)
Liver disease predominates in a mouse model for mild human Zellweger spectrum disorder
Kevin Berendse et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Oral Cholic Acid Is Efficacious and Well Tolerated in Patients With Bile Acid Synthesis and Zellweger Spectrum Disorders
James E. Heubi et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2017)
Human disorders of peroxisome metabolism and biogenesis
Hans R. Waterham et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Cholic acid therapy in Zellweger spectrum disorders
Kevin Berendse et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2016)
Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines
Nancy E. Braverman et al.
MOLECULAR GENETICS AND METABOLISM (2016)
Negative feedback regulation of bile acid metabolism: Impact on liver metabolism and diseases
John Y. L. Chiang
HEPATOLOGY (2015)
Zellweger spectrum disorders: clinical overview and management approach
Femke C. C. Klouwer et al.
ORPHANET JOURNAL OF RARE DISEASES (2015)
PEROXISOME BIOGENESIS DISORDERS: BIOLOGICAL, CLINICAL AND PATHOPHYSIOLOGICAL PERSPECTIVES
Nancy E. Braverman et al.
DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS (2013)
Peroxisomes, Peroxisomal Diseases, and the Hepatotoxicity Induced by Peroxisomal Metabolites
Ronald J.A. Wanders et al.
CURRENT DRUG METABOLISM (2012)
Oral Cholic Acid for Hereditary Defects of Primary Bile Acid Synthesis: A Safe and Effective Long-term Therapy
Emmanuel Gonzales et al.
GASTROENTEROLOGY (2009)
Toxicity of peroxisomal C27-bile acid intermediates
Sacha Ferdinandusse et al.
MOLECULAR GENETICS AND METABOLISM (2009)
Bile acid treatment alters hepatic disease and bile acid transport in peroxisome-deficient PEX2 Zellweger mice
Megan H. Keane et al.
HEPATOLOGY (2007)
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
B Goodwin et al.
MOLECULAR CELL (2000)
Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury
SL Friedman
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
